Please enable JavaScript to continue using this application.

Compare $REPL vs $TRAX | Chartloom

Compare

$REPL vs $TRAX

Replimune Group Inc · First Tracks Biotherapeutics Inc

REPL

Replimune Group Inc

TRAX

First Tracks Biotherapeutics Inc

Compare $REPL vs $TRAX

Comparing Replimune Group Inc and First Tracks Biotherapeutics Inc

REPLReplimune Group Inc

TRAXFirst Tracks Biotherapeutics Inc

REPLReplimune Group Inc

Market cap

$1.13B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

40.24x

Rev growth (TTM)

—

YTD performance

50.8%

52W performance

188.6%

FCF yield

-24.9%

TRAXFirst Tracks Biotherapeutics Inc

Market cap

$1.11B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

67.6%

52W performance

67.6%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

REPL

TRAX

Detailed metrics comparison

REPL

Replimune Group Inc

TRAX

First Tracks Biotherapeutics Inc

Market Cap

REPL$1.13B

TRAX$1.11B

Enterprise Value

REPL$1.05B

TRAX$943M

Price

REPL$13.42

TRAX$31.85

P/E Ratio

REPLN/A

TRAXN/A

P/S Ratio

REPL0.00x

TRAX0.00x

EV/Sales

REPL0.00x

TRAX0.00x

EV/EBITDA

REPL0.00x

TRAX0.00x

P/B Ratio

REPL11.66x

TRAX7.04x

P/FCF Ratio

REPLN/A

TRAXN/A

EV/FCF

REPL-3.75x

TRAX0.00x

PEG Ratio

REPLN/A

TRAXN/A

Forward P/E (NTM)

REPLN/A

TRAXN/A

Forward P/S (NTM)

REPL40.24x

TRAXN/A

Revenue (TTM)

REPL$0

TRAX$0

Revenue Growth (YoY)

REPLN/A

TRAXN/A

Forward Rev Growth

REPL397.3%

TRAX0.0%

Gross Margin (TTM)

REPL0.0%

TRAX0.0%

Operating Margin (TTM)

REPL0.0%

TRAX0.0%

EBITDA Margin (TTM)

REPL0.0%

TRAX0.0%

Net Margin (TTM)

REPL0.0%

TRAX0.0%

FCF Margin (TTM)

REPLN/A

TRAXN/A

Net Income (TTM)

REPL$-297M

TRAX$-84M

FCF (TTM)

REPL$-281M

TRAX$0

EPS (TTM)

REPL-$3.07

TRAX-$2.40

ROE (TTM)

REPL-15932.0%

TRAX0.0%

ROA (TTM)

REPL-9084.0%

TRAX0.0%

ROIC (TTM)

REPL-10727.0%

TRAX0.0%

Cash

REPL$185M

TRAX$168M

Debt

REPL$109M

TRAX$0

Net Cash/Debt

REPL$77M

TRAX$168M

Current Ratio (TTM)

REPL5.23x

TRAX14.28x

Quick Ratio (TTM)

REPL5.09x

TRAX14.08x

Debt/Equity (TTM)

REPL1.03x

TRAX0.00x

Debt/Assets (TTM)

REPL0.0%

TRAX0.0%

Interest Coverage (TTM)

REPLN/A

TRAXN/A

Net Debt/EBITDA (TTM)

REPL0.00x

TRAX0.00x

Beta

REPL0.97

TRAX1.60

52W Performance

REPL188.6%

TRAX67.6%

YTD Performance

REPL50.8%

TRAX67.6%

% from 52W High

REPL-17.8%

TRAX-36.2%

% from 52W Low

REPL794.7%

TRAX116.4%

Asset Turnover (TTM)

REPL0.00x

TRAX0.00x

FCF Yield (TTM)

REPL-24.9%

TRAX0.0%

Earnings Yield (TTM)

REPL-26.3%

TRAX-7.5%

Dividend Yield (TTM)

REPLN/A

TRAXN/A

Rule of 40

REPL0.0

TRAX0.0

EV/GP/RG

REPLN/A

TRAXN/A

Ticker research

View REPL research View TRAX research

Metric	REPL Replimune Group Inc	TRAX First Tracks Biotherapeutics Inc
Market & Valuation
Market Cap	$1.13B	$1.11B
Enterprise Value	$1.05B	$943M
Price	$13.42	$31.85
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	11.66x	7.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.75x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	40.24x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	397.3%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-297M	$-84M
FCF (TTM)	$-281M	$0
EPS (TTM)	-$3.07	-$2.40
ROE (TTM)	-15932.0%	0.0%
ROA (TTM)	-9084.0%	0.0%
ROIC (TTM)	-10727.0%	0.0%
Financial Health
Cash	$185M	$168M
Debt	$109M	$0
Net Cash/Debt	$77M	$168M
Current Ratio (TTM)	5.23x	14.28x
Quick Ratio (TTM)	5.09x	14.08x
Debt/Equity (TTM)	1.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	1.60
52W Performance	188.6%	67.6%
YTD Performance	50.8%	67.6%
% from 52W High	-17.8%	-36.2%
% from 52W Low	794.7%	116.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-24.9%	0.0%
Earnings Yield (TTM)	-26.3%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View REPL research	View TRAX research

Valuation

P/S Ratio

REPL

0.00x

TRAX

0.00x

EV/FCF

REPL

-3.75x

TRAX

0.00x

Growth & revenue

Forward Revenue Growth

REPL

397.3%

TRAX

0.0%

Profitability & performance

Gross Margin

REPL

0.0%

TRAX

0.0%

ROE

TRAX

0.0%

REPL

-15932.0%

FCF Yield %

TRAX

0.0%

REPL

-24.9%

52-Week Performance

REPL

188.6%

TRAX

67.6%

Detailed metrics comparison

REPL

Replimune Group Inc

TRAX

First Tracks Biotherapeutics Inc

Market Cap

REPL$1.13B

TRAX$1.11B

Enterprise Value

REPL$1.05B

TRAX$943M

Price

REPL$13.42

TRAX$31.85

P/E Ratio

REPLN/A

TRAXN/A

P/S Ratio

REPL0.00x

TRAX0.00x

EV/Sales

REPL0.00x

TRAX0.00x

EV/EBITDA

REPL0.00x

TRAX0.00x

P/B Ratio

REPL11.66x

TRAX7.04x

P/FCF Ratio

REPLN/A

TRAXN/A

EV/FCF

REPL-3.75x

TRAX0.00x

PEG Ratio

REPLN/A

TRAXN/A

Forward P/E (NTM)

REPLN/A

TRAXN/A

Forward P/S (NTM)

REPL40.24x

TRAXN/A

Revenue (TTM)

REPL$0

TRAX$0

Revenue Growth (YoY)

REPLN/A

TRAXN/A

Forward Rev Growth

REPL397.3%

TRAX0.0%

Gross Margin (TTM)

REPL0.0%

TRAX0.0%

Operating Margin (TTM)

REPL0.0%

TRAX0.0%

EBITDA Margin (TTM)

REPL0.0%

TRAX0.0%

Net Margin (TTM)

REPL0.0%

TRAX0.0%

FCF Margin (TTM)

REPLN/A

TRAXN/A

Net Income (TTM)

REPL$-297M

TRAX$-84M

FCF (TTM)

REPL$-281M

TRAX$0

EPS (TTM)

REPL-$3.07

TRAX-$2.40

ROE (TTM)

REPL-15932.0%

TRAX0.0%

ROA (TTM)

REPL-9084.0%

TRAX0.0%

ROIC (TTM)

REPL-10727.0%

TRAX0.0%

Cash

REPL$185M

TRAX$168M

Debt

REPL$109M

TRAX$0

Net Cash/Debt

REPL$77M

TRAX$168M

Current Ratio (TTM)

REPL5.23x

TRAX14.28x

Quick Ratio (TTM)

REPL5.09x

TRAX14.08x

Debt/Equity (TTM)

REPL1.03x

TRAX0.00x

Debt/Assets (TTM)

REPL0.0%

TRAX0.0%

Interest Coverage (TTM)

REPLN/A

TRAXN/A

Net Debt/EBITDA (TTM)

REPL0.00x

TRAX0.00x

Beta

REPL0.97

TRAX1.60

52W Performance

REPL188.6%

TRAX67.6%

YTD Performance

REPL50.8%

TRAX67.6%

% from 52W High

REPL-17.8%

TRAX-36.2%

% from 52W Low

REPL794.7%

TRAX116.4%

Asset Turnover (TTM)

REPL0.00x

TRAX0.00x

FCF Yield (TTM)

REPL-24.9%

TRAX0.0%

Earnings Yield (TTM)

REPL-26.3%

TRAX-7.5%

Dividend Yield (TTM)

REPLN/A

TRAXN/A

Rule of 40

REPL0.0

TRAX0.0

EV/GP/RG

REPLN/A

TRAXN/A

Ticker research

View REPL research View TRAX research

Metric	REPL Replimune Group Inc	TRAX First Tracks Biotherapeutics Inc
Market & Valuation
Market Cap	$1.13B	$1.11B
Enterprise Value	$1.05B	$943M
Price	$13.42	$31.85
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	11.66x	7.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.75x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	40.24x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	397.3%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-297M	$-84M
FCF (TTM)	$-281M	$0
EPS (TTM)	-$3.07	-$2.40
ROE (TTM)	-15932.0%	0.0%
ROA (TTM)	-9084.0%	0.0%
ROIC (TTM)	-10727.0%	0.0%
Financial Health
Cash	$185M	$168M
Debt	$109M	$0
Net Cash/Debt	$77M	$168M
Current Ratio (TTM)	5.23x	14.28x
Quick Ratio (TTM)	5.09x	14.08x
Debt/Equity (TTM)	1.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	1.60
52W Performance	188.6%	67.6%
YTD Performance	50.8%	67.6%
% from 52W High	-17.8%	-36.2%
% from 52W Low	794.7%	116.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-24.9%	0.0%
Earnings Yield (TTM)	-26.3%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View REPL research	View TRAX research